CHEUNG; Atwood Kim

Patent Applications and Registrations

Patent applications and USPTO patent grants for CHEUNG; Atwood Kim.The latest application filed is for "heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses thereof".

Company Profile

5.11.14

CHEUNG; Atwood Kim - Arlington MA
Cheung; Atwood Kim - Cambridge MA US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Heteroaryl Substituted Spiropiperidinyl Derivatives And Pharmaceutical Uses Thereof App 20220048909 - BUSHABOINA; Mallesh ; et al.	2022-02-17
1,4-disubstituted pyridazine analogs thereof and methods for treating SMN-deficiency-related conditions Grant 11,229,648 - Cheung , et al. January 25, 2	2022-01-25
1,4-disubstituted Pyridazine Analogs There Of And Methods For Treating Smn-deficiency-related Conditions App 20200345732 - CHEUNG; Atwood Kim ; et al.	2020-11-05
1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions Grant 10,758,533 - Cheung , et al. Sep	2020-09-01
1,4-disubstituted Pyridazine Analogs There Of And Methods For Treating Smn-deficiency-related Conditions App 20190358226 - CHEUNG; Atwood Kim ; et al.	2019-11-28
1,4-disubstituted Pyridazine Quinolne Analogs There Of And Methods For Treating Smn-deficiency-related Conditions App 20190160062 - CHEUNG; Atwood Kim ; et al.	2019-05-30
1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions Grant 10,195,196 - Cheung , et al. Fe	2019-02-05
1,4-disubstituted Pyridazine Analogs There Of And Methods For Treating Smn-deficiency-related Conditions App 20170290828 - CHEUNG; Atwood Kim ; et al.	2017-10-12
1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions Grant 9,545,404 - Cheung , et al. January 17, 2	2017-01-17
1,4-disubstituted Pyridazine Quinolne Analogs There Of And Methods For Treating Smn-deficiency-related Conditions App 20160184305 - CHEUNG; Atwood Kim ; et al.	2016-06-30
4-oxo-3,5,7,8-tetrahydro-4H-pyrano[4,3-d]pyrminidinyl compounds for use as tankyrase inhibitors Grant 9,227,982 - Cheung , et al. January 5, 2	2016-01-05
2-piperidin-1-yl-acetamide compounds for use as tankyrase inhibitors Grant 9,181,266 - Cheung , et al. November 10, 2	2015-11-10
4-oxo-3,5,7,8-tetrahydro-4h-pyrano[4,3-d]pyrminidinyl Compounds For Use As Tankyrase Inhibitors App 20150210709 - Cheung; Atwood Kim ; et al.	2015-07-30
Novel 2-piperidin-1-yl-acetamide Compounds For Use As Tankyrase Inhibitors App 20150025070 - Cheung; Atwood Kim ; et al.	2015-01-22
1,4-disubstituted Pyridazine Analogs There Of And Methods For Treating Smn-deficiency-related Conditions App 20140213570 - CHEUNG; Atwood Kim ; et al.	2014-07-31
1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions Grant 8,729,263 - Cheung , et al. May 20, 2	2014-05-20
1,4-disubstituted Pyridazine Analogs There Of And Methods For Treating Smn-deficiency-related Conditions App 20140051672 - CHEUNG; Atwood Kim ; et al.	2014-02-20
Tie-2 modulators and methods of use Grant 8,013,156 - Canne Bannen , et al. September 6, 2	2011-09-06
Tie-2 Modulators and Methods of Use App 20070275952 - Bannen; Lynne Canne ; et al.	2007-11-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.